Vestal Point Capital, LP I Teos Therapeutics, Inc. Transaction History
Vestal Point Capital, LP
- $1.34 Trillion
- Q2 2024
A detailed history of Vestal Point Capital, LP transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 1,750,000 shares of ITOS stock, worth $15.7 Million. This represents 1.94% of its overall portfolio holdings.
Number of Shares
1,750,000Holding current value
$15.7 Million% of portfolio
1.94%Shares
1 transactions
Others Institutions Holding ITOS
# of Institutions
151Shares Held
36.3MCall Options Held
653KPut Options Held
1.48M-
Black Rock Inc. New York, NY3.73MShares$33.5 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.52MShares$31.5 Million0.79% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.25MShares$29.2 Million1.7% of portfolio
-
Boxer Capital, LLC San Diego, CA2.95MShares$26.4 Million2.43% of portfolio
-
Mpm Asset Management LLC Cambridge, MA2.74MShares$24.6 Million22.32% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $319M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...